๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
In recent years, diabetes has emerged as one of the most significant co-dis...
Status
Completed
Location
Children's Hospital of Philadelphia and University of Pennsylvania
Start Date
2013-06
Trial ID
NCT01879228
Treatments Being Tested
A clinical study to determine the safety, efficacy and the way sitagliptin ...
Status
Completed
Location
Multiple Locations
Start Date
2007-02-14
Trial ID
NCT00704132
Treatments Being Tested
The aim of this study is to examine the effect of GLP-1 and other gut-secre...
Status
Completed
Location
Hvidovre University Hospital
Start Date
2014-04
Trial ID
NCT02336659
Treatments Being Tested
This study will examine the safety and efficacy of the addition of sitaglip...
Status
Completed
Location
Multiple Locations
Start Date
2009-04-15
Trial ID
NCT00885352
Treatments Being Tested
Epidemiologic, social and economic burdens of type 2 diabetes mellitus (T2D...
Status
Completed
Location
Azienda Ospedaliero Universitaria di Parma
Start Date
2020-09-01
Trial ID
NCT04271189
Treatments Being Tested
This study investigated a 4-week adjunctive therapy of either a GLP-1 analo...
Status
Completed
Location
Profil Institut fรผr Stoffwechselforschung GmbH
Start Date
2008-01
Trial ID
NCT00971659
This trial is conducted in Japan. The purpose is to compare the safety of o...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2014-10-02
Trial ID
NCT02254291
Treatments Being Tested
The study is a multicenter, prospective, open-label, randomized pilot study...
Status
Completed
Location
Grady Memorial Hospital
Start Date
2011-08
Trial ID
NCT01378117
Treatments Being Tested
The purpose of this study is to determine the pharmacogenetics, pharmacokin...
Status
Completed
Location
University of Colorado Denver
Start Date
2009-11
Trial ID
NCT01112670
Treatments Being Tested
Phase 3 study to compare treatment with ITCA 650 to sitagliptin when added ...
Status
Withdrawn
Location
Intarcia Therapeutics, Inc
Start Date
2013-02
Trial ID
NCT01455909
Treatments Being Tested